Cargando…
Winter Is Coming! Clinical, Immunologic, and Practical Considerations for Vaccinating Patients With Inflammatory Bowel Disease During the Coronavirus Disease-2019 Pandemic
Autores principales: | Melmed, Gil Y., Rubin, David T., McGovern, Dermot P.B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the AGA Institute
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553998/ https://www.ncbi.nlm.nih.gov/pubmed/33065064 http://dx.doi.org/10.1053/j.gastro.2020.10.013 |
Ejemplares similares
-
SARS-CoV-2 vaccination for patients with inflammatory bowel diseases: recommendations from an international consensus meeting
por: Siegel, Corey A, et al.
Publicado: (2021) -
Post-Vaccination Symptoms after A Third Dose of mRNA SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease
por: Li, Dalin, et al.
Publicado: (2021) -
Reply
por: Melmed, Gil, et al.
Publicado: (2021) -
Postvaccination Symptoms After a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease: Results From CORALE-IBD
por: Li, Dalin, et al.
Publicado: (2022) -
Reappraisal of Coronavirus Disease 2019 Risk for Patients With Inflammatory Bowel Disease: Withdrawal of the British Society of Gastroenterology Inflammatory Bowel Disease Risk Grid
por: Ungaro, Ryan C., et al.
Publicado: (2023)